TY  - JOUR
AU  - Ramos Acosta, Carlos
AU  - Huerta Pantoja, Laura
AU  - Salazar Hidalgo, Milton Eduardo
AU  - Mayol, Elsa
AU  - Jiménez Vega, Selene
AU  - García Peña, Pablo
AU  - Jordi Cruz, Jenifeer
AU  - Baquero, Cristina
AU  - Porras Gallo, María Almudena
AU  - Íñigo Rodríguez, Belén
AU  - Benavente Cuesta, Celina
AU  - Candel González, Francisco Javier
AU  - Anguita Mandly, Eduardo Luis
PY  - 2024
DO  - 10.3390/ijms25094887
SN  - 1422-0067
UR  - https://hdl.handle.net/20.500.14352/105610
T2  - International journal of molecular sciences
AB  - Multiple myeloma is an incurable plasma cell malignancy. Most patients end up relapsing and developing resistance to antineoplastic drugs, like bortezomib. Antibiotic tigecycline has activity against myeloma. This study analyzed tigecycline and...
LA  - eng
M2  - 1
PB  - MDPI
KW  - Hematología
KW  - Mieloma
TI  - Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production
TY  - journal article
VL  - 25
ER  -